Global Health Ltd

Global Health Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Global Health Ltd

₹ 1,246 -0.01%
01 Dec 3:52 p.m.
medanta.org BSE: 543654 NSE: MEDANTA
About

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.[1]

Key Points

Hospital Count[1] Global Health operates five hospitals under the "Medanta" brand in Gurugram, Indore, Ranchi, Lucknow, and Patna, with one more hospital under construction in Noida. The company provides services in over 30 medical specialties, employing 1,750+ doctors across a total area of 4.7 million square feet.
The operational hospitals have 3,008 installed beds. In addition, Global Health runs 6 multi-specialty clinics in locations such as DLF Cybercity Gurugram, Delhi Airport, South Delhi, Darbhanga, Patna, and Subhash Chowk Gurugram.[2]

Website BSE NSE
  • Market Cap ₹ 33,498 Cr.
  • Current Price ₹ 1,246
  • High / Low ₹ 1,456 / 995
  • Stock P/E 63.8
  • Book Value ₹ 141
  • Dividend Yield 0.04 %
  • ROCE 19.6 %
  • ROE 15.2 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 37.1% CAGR over last 5 years

Cons

  • Stock is trading at 8.82 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap BSE Allcap

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
494 490 506 551 580 565 724 611 665 812 803 882 926
391 394 400 435 452 439 560 479 514 611 608 688 734
Operating Profit 103 95 106 115 128 126 164 132 150 202 195 195 193
OPM % 21% 19% 21% 21% 22% 22% 23% 22% 23% 25% 24% 22% 21%
13 13 25 27 26 23 30 27 24 19 -24 43 39
Interest 7 6 6 6 6 6 10 6 5 8 7 6 9
Depreciation 22 22 20 20 22 22 35 23 25 37 38 33 37
Profit before tax 87 80 104 116 127 121 149 130 144 175 126 198 185
Tax % 25% 26% 22% 26% 25% 28% 26% 26% 27% 25% 26% 23% 24%
65 59 81 86 95 87 109 96 104 131 93 152 140
EPS in Rs 2.58 2.19 3.02 3.21 3.54 3.25 4.08 3.59 3.89 4.89 3.48 5.65 5.22
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
1,277 1,343 1,441 1,472 1,227 1,765 1,974 2,975 3,204 3,424
1,158 1,218 1,297 1,253 1,054 1,384 1,551 2,222 2,432 2,640
Operating Profit 119 125 144 219 173 381 423 753 772 784
OPM % 9% 9% 10% 15% 14% 22% 21% 25% 24% 23%
67 49 64 43 28 35 47 91 41 77
Interest 19 24 21 33 29 33 32 51 41 30
Depreciation 77 86 91 99 88 87 86 134 150 146
Profit before tax 89 64 97 131 84 296 352 659 623 684
Tax % 39% 42% 35% 22% 32% 26% 25% 26% 26%
54 37 63 103 57 219 263 486 462 517
EPS in Rs 11.21 7.70 12.81 20.82 11.55 8.64 9.82 18.11 17.18 19.24
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 17%
3 Years: 22%
TTM: 33%
Compounded Profit Growth
10 Years: %
5 Years: 37%
3 Years: 32%
TTM: 32%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 40%
1 Year: 16%
Return on Equity
10 Years: %
5 Years: 14%
3 Years: 15%
Last Year: 15%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 48 48 49 49 50 51 54 54 54 54
Reserves 1,070 1,141 1,230 1,341 1,434 1,689 2,435 2,983 3,444 3,741
215 201 168 51 228 308 288 424 337 256
303 318 310 517 291 314 402 523 606 1,004
Total Liabilities 1,637 1,709 1,758 1,958 2,002 2,361 3,179 3,984 4,441 5,054
966 1,162 869 929 851 827 810 1,645 1,861 2,453
CWIP 8 7 5 3 4 6 75 280 458 304
Investments 21 0 356 500 626 734 765 362 366 367
642 540 528 525 521 794 1,529 1,698 1,757 1,930
Total Assets 1,637 1,709 1,758 1,958 2,002 2,361 3,179 3,984 4,441 5,054

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
124 152 193 201 235 431 559 528
-112 -104 -45 -250 -313 -257 -519 -638
-6 -49 -56 -37 98 404 -379 -94
Net Cash Flow 6 -1 92 -86 20 577 -339 -205

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 31 41 42 37 39 36 32 26 33
Inventory Days 36 26 26 37 39 33 34 29 24
Days Payable 132 124 142 135 134 84 113 84 81
Cash Conversion Cycle -66 -56 -74 -61 -56 -16 -48 -29 -24
Working Capital Days -31 -16 -7 -11 -20 -6 -27 -24 -14
ROCE % 6% 8% 11% 7% 17% 16% 23% 20%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
33.08% 33.08% 33.07% 33.06% 33.05% 33.04% 33.04% 33.04% 33.03% 33.03% 33.01% 33.01%
9.36% 9.89% 10.58% 10.69% 11.36% 12.10% 12.94% 12.21% 12.48% 11.76% 11.54% 11.41%
12.55% 12.34% 10.79% 10.93% 11.15% 10.25% 10.57% 11.11% 10.51% 11.93% 12.20% 12.97%
45.01% 44.67% 45.55% 45.31% 44.45% 44.60% 43.44% 43.64% 43.98% 43.28% 43.19% 42.56%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.06%
No. of Shareholders 1,21,4071,07,1201,09,7981,16,6271,24,7751,66,2531,55,3071,49,7221,48,6331,54,6881,56,3721,55,806

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls